Clinical trial
A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Budesonide/Formoterol Inhalation Powder in Adults With Asthma
NCT07790159 is registered in ClinicalTrials.gov with Shanghai Xin Huanghe Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Budesonide/Formoterol Inhalation Powder in Adults With Asthma
- Lead sponsor
- Shanghai Xin Huanghe Pharmaceutical Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 21, 2024
- Completion date
- November 7, 2024
- Enrollment
- 338 (actual)
- Sites
- 28
Conditions
As the registry lists them; a condition with its own page is linked.